Avapro Oral Tablet 150Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Avapro: Oral tablet (150mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_5051.JPG
Avapro 150mg Tab
Bristol Myers Squibb Co
Pill Identification: 2772  |  LOGO

What is this Medicine?

IRBESARTAN (ir be SAR tan) is used to treat high blood pressure. This drug also slows down the progression of kidney disease in diabetic patients.

CVS Pharmacy Patient Statistics for Avapro: Oral tablet(150mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Avapro 150mg Tablet

NDC: 000872772
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Diabetic Nephropathy, Proteinuria, Hypertension

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Avapro 150mg Tablet
Drug Image file DrugItem_5051.JPG
Bristol Myers Squibb Co
Pill Identification: 2772  |  LOGO
Shape: oval
Color: white

Reported Side Effects for Avapro 150mg Tablet

Stomach Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Muscle Cramps Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Heart Attack Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Vomiting Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Abnormal Heart Rhythm Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Chills Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Conjunctivitis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Bruise Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Skin Redness Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Flushing Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
High Blood Pressure Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Impotence (erectile Dysfunction) Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Decreased Sexual Desire Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Increased Sexual Desire Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Paresthesias Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Visual Impairment Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Weakness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Wheezing Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Upset Stomach Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Chest Pain Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Suddenly Stopped Heart Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Constipation Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Depression Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Drowsiness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Nose Bleed Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Fever Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Gas Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Gout Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Heart Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Shaking Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
High Blood Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Low Blood Pressure Incidence:
0.1-0.4%*
Severity: MODERATE
Onset: RAPID
Low White Blood Cells Incidence:
0.3%*
Severity: MODERATE
Onset: DELAYED
Postural Low Blood Pressure Incidence:
0.4-5.4%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
1.0-10.2%*
Severity: MILD
Onset: EARLY
Nervousness Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
>1.0%*
Severity: MODERATE
Onset: RAPID
Rhinitis Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Flu Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Muscle And/Or Bone Pain Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Chest Pain Incidence:
>1.0%*
Severity: MODERATE
Onset: EARLY
Sore Throat Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Swelling Incidence:
>1.0%*
Severity: MODERATE
Onset: DELAYED
Heartburn Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Cough Incidence:
2.8%*
Severity: MILD
Onset: DELAYED
Loose Stools Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Tired Incidence:
4.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Avapro 150mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Alcohol and Avapro 150mg Tablet(Irbesartan)
Alcohol and Antihypertensives(Irbesartan)
Although an interaction is possible, Ethanol (alchohol) and Antihypertensive Agents (drugs used to reduce high blood pressure) may be used together. Ethanol or alchohol-containing beverages may increase the effects of Antihypertensive Agents on your blood pressure. If the blood pressure drops too low while taking Ethanol and Antihypertensive Agents, you may become dizzy or feel faint. To limit this interaction, avoid alcohol-containing beverages while taking medicines to lower your blood pressure. Do not stand or sit up too quickly. Contact your prescriber if you have dizziness which does not go away.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Avapro

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5